Clinical Trials Directory

Trials / Completed

CompletedNCT00081575

Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Intravenous Tigecycline Vs Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
434 (actual)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To compare the efficacy and safety of IV tigecycline to IV levofloxacin in the treatment of subjects with CAP requiring hospitalization.

Conditions

Interventions

TypeNameDescription
DRUGTigecycline
DRUGLevofloxacin

Timeline

Start date
2004-01-01
Primary completion
2005-03-01
Completion
2005-03-01
First posted
2004-04-19
Last updated
2013-02-08

Source: ClinicalTrials.gov record NCT00081575. Inclusion in this directory is not an endorsement.